[ed note: Michael Jorrin is longtime medical writer who has been sharing his thoughts with our readers as “Doc Gumshoe” for several years (he’s not a doctor, I gave him the name). He generally covers medical and health news and sometimes health promotions and hype, but he rarely opines about investments or specific stocks. All of his past […]
Articles
Dawn of the Planet of the TLOGlodytes![Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own, and he has agreed to our trading restrictions.] Want to see something really cool? A hot video clip from a steamy biotech thriller? Watch this. Better yet, when you pull up the video viewing frame, […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Radius ($RDUS) assinged PDUFA date of March 30, 2017 for Abaloparatide-SC. Recently reported strong cash position of $40...
Radius ($RDUS) up 10% today. No particular news that I can find. It was starting to do well technically - may just be te...
Radius $RDUS is primo…..really a top shelf company with great ideas and superior execution. People in this one should ...
I may look at entering CLCD here. I have a sneaking feeling they may become a category killer in migraine the way Radius...
Radius (RDUS) and abaloparatide may soon be the standard of care for women with osteoporosis. http://finance.yahoo.com/...
Radius $RDUS is primo.....really a top shelf company with great ideas and superior execution. People in this one should ...
Good news for Radius (RDUS) today. Long RDUS. http://finance.yahoo.com/news/journal-clinical-endocrinology-metabolism-p...